Form 4: Ulta Beauty CFO Granted 5,474 Restricted Stock Units
Insider Transaction Report
Ulta Beauty's Chief Financial Officer, Christopher DelOrefice, was granted 5,474 restricted stock units vesting over two years.
Summary
- Christopher DelOrefice, Ulta Beauty's Chief Financial Officer, received a grant of 5,474 restricted stock units (RSUs).
- The grant consists of two tranches: 1,825 RSUs vesting 100% on December 9, 2026, and 3,649 RSUs vesting 100% on December 9, 2027.
- These RSUs represent common stock and were acquired at a price of $0, which is typical for equity grants.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.
Sentiment
Score: 7
Explanation: The filing reports a routine equity grant to a key executive, which is generally a positive sign for executive retention and alignment with shareholder interests, but it is not a significant market-moving event on its own.
Positives
- The grant of restricted stock units aligns management's long-term interests with those of shareholders.
- The transaction was pre-planned under a Rule 10b5-1(c) plan, indicating a structured and compliant approach to equity compensation.
Future Outlook
The vesting schedule for the granted restricted stock units indicates future equity ownership for the Chief Financial Officer in 2026 and 2027, aligning long-term incentives with company performance.
Industry Context
This transaction represents a routine equity compensation event for a senior executive at a publicly traded company, a common practice across various industries to incentivize long-term performance and retention. It does not directly reflect broader industry trends or competitive shifts within the beauty retail sector.
Comparison to Industry Standards
- Equity grants to senior executives, particularly in the form of restricted stock units with multi-year vesting schedules, are a standard practice in corporate compensation across industries, including retail and beauty.
- Companies like Sephora (LVMH), Estée Lauder, and L'Oréal also utilize similar long-term incentive plans to retain and motivate key personnel.
- The specific number of units granted would typically be benchmarked against peer companies of similar size and market capitalization, considering the executive's role and performance.
Stakeholder Impact
- Shareholders: The grant aligns the CFO's long-term interests with shareholder value creation.
- Employees: Standard executive compensation practices can positively influence overall employee morale and retention strategies.
Next Steps
- Vesting of 1,825 restricted stock units on December 9, 2026.
- Vesting of 3,649 restricted stock units on December 9, 2027.
Key Dates
| Date | Description |
|---|---|
| 12/09/2025 | Date of RSU grant to Christopher DelOrefice. |
| 12/10/2025 | Filing date of the Form 4. |
| 12/09/2026 | Vesting date for 1,825 restricted stock units. |
| 12/09/2027 | Vesting date for 3,649 restricted stock units. |
Recommendation
holdThis Form 4 filing reports a routine equity grant to a senior executive, which is a standard part of compensation and retention strategies. It does not provide new information that would fundamentally alter the investment thesis for Ulta Beauty, nor does it indicate any significant operational or financial changes. Therefore, an investor would likely maintain their current position based solely on this filing.
Keywords
Ulta Beauty, ULTA, Christopher DelOrefice, CFO, Restricted Stock Units, RSU, Insider Transaction, Equity Compensation, Stock Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.